|
INTS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.602350E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.59348999999587E-05 |
| Normal-vs-Stage2 |
1.017360E-01 |
| Normal-vs-Stage3 |
3.430400E-01 |
| Normal-vs-Stage4 |
6.277600E-01 |
| Stage1-vs-Stage2 |
2.332000E-01 |
| Stage1-vs-Stage3 |
1.602450E-03 |
| Stage1-vs-Stage4 |
1.376120E-03 |
| Stage2-vs-Stage3 |
3.079000E-01 |
| Stage2-vs-Stage4 |
2.196200E-01 |
| Stage3-vs-Stage4 |
6.948600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.300900E-03 |
| Normal-vs-AfricanAmerican |
7.144400E-01 |
| Normal-vs-Asian |
3.53830000000555E-05 |
| Caucasian-vs-AfricanAmerican |
7.821600E-02 |
| Caucasian-vs-Asian |
1.701800E-02 |
| AfricanAmerican-vs-Asian |
3.183400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.461620E-02 |
| Normal-vs-Female |
3.181400E-04 |
| Male-vs-Female |
8.576400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.373600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.583900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.405700E-02 |
| Normal-vs-Age(81-100Yrs) |
7.682800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.527400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.545000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.424800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.066500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.603550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.238400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.878100E-03 |
| Normal-vs-Grade 2 |
4.2066999999979E-05 |
| Normal-vs-Grade 3 |
5.990200E-02 |
| Normal-vs-Grade 4 |
9.562200E-01 |
| Grade 1-vs-Grade 2 |
9.985700E-02 |
| Grade 1-vs-Grade 3 |
1.976420E-03 |
| Grade 1-vs-Grade 4 |
6.805300E-04 |
| Grade 2-vs-Grade 3 |
5.942200E-03 |
| Grade 2-vs-Grade 4 |
1.615190E-03 |
| Grade 3-vs-Grade 4 |
1.222630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.09320000052371E-07 |
| Normal-vs-ccB subtype |
1.092990E-01 |
| ccA subtype-vs-ccB subtype |
1.382420E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.500870E-03 |
| Normal-vs-N1 |
4.140400E-01 |
| N0-vs-N1 |
6.605600E-01 |
|
|
